Rankings
▼
Calendar
ALDX Q1 2016 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ALDX
Aldeyra Therapeutics, Inc.
$290M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-0.51
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$609,108
Balance Sheet
Total Assets
$23M
Total Liabilities
$3M
Stockholders' Equity
$21M
Cash & Equivalents
$10M
← FY 2016
All Quarters
Q2 2016 →